Zacks Investment Research upgraded shares of Quaker Chemical (NYSE:KWR) from a sell rating to a hold rating in a research report sent to investors on Tuesday.
According to Zacks, “Quaker Chemical Corporation develops, produces and markets a range of formulated chemical specialty products for various heavy industrial and manufacturing applications and, in addition, offers and markets chemical management services (CMS). The Company operates in three segments: Metalworking process chemicals, Coatings and Other chemical products. The Metalworking process chemicals segment includes industrial process fluids for various heavy industrial and manufacturing applications. Coatings segment includes temporary and permanent coatings for metal and concrete products and chemical milling maskants. “
A number of other equities analysts have also recently issued reports on the stock. ValuEngine cut shares of Quaker Chemical from a buy rating to a hold rating in a research report on Friday, December 1st. B. Riley set a $165.00 target price on shares of Quaker Chemical and gave the stock a hold rating in a research report on Monday, November 20th. Finally, FBR & Co set a $165.00 target price on shares of Quaker Chemical and gave the stock a hold rating in a research report on Friday, October 27th. One investment analyst has rated the stock with a sell rating and five have assigned a hold rating to the stock. Quaker Chemical has a consensus rating of Hold and an average price target of $163.50.
Quaker Chemical (NYSE:KWR) last announced its earnings results on Thursday, October 26th. The specialty chemicals company reported $1.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.26 by $0.06. The company had revenue of $212.90 million during the quarter, compared to analysts’ expectations of $200.71 million. Quaker Chemical had a net margin of 5.93% and a return on equity of 15.43%. The firm’s quarterly revenue was up 11.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.25 earnings per share. research analysts predict that Quaker Chemical will post 5 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 31st. Stockholders of record on Wednesday, January 17th will be issued a dividend of $0.355 per share. The ex-dividend date is Tuesday, January 16th. This represents a $1.42 dividend on an annualized basis and a dividend yield of 0.91%. Quaker Chemical’s dividend payout ratio (DPR) is presently 39.66%.
In other news, Director Adrian Steeples sold 4,911 shares of Quaker Chemical stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $155.71, for a total transaction of $764,691.81. Following the completion of the sale, the director now directly owns 6,193 shares in the company, valued at $964,312.03. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Mark Douglas sold 1,575 shares of Quaker Chemical stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $164.23, for a total transaction of $258,662.25. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 23,938 shares of company stock valued at $3,786,305. Insiders own 3.60% of the company’s stock.
Several hedge funds and other institutional investors have recently modified their holdings of the company. Oppenheimer Asset Management Inc. grew its holdings in shares of Quaker Chemical by 0.6% during the second quarter. Oppenheimer Asset Management Inc. now owns 3,929 shares of the specialty chemicals company’s stock worth $571,000 after buying an additional 25 shares in the last quarter. The Manufacturers Life Insurance Company grew its holdings in shares of Quaker Chemical by 0.3% during the second quarter. The Manufacturers Life Insurance Company now owns 10,067 shares of the specialty chemicals company’s stock worth $1,463,000 after buying an additional 26 shares in the last quarter. Stifel Financial Corp grew its holdings in shares of Quaker Chemical by 0.9% during the second quarter. Stifel Financial Corp now owns 3,011 shares of the specialty chemicals company’s stock worth $436,000 after buying an additional 28 shares in the last quarter. Amalgamated Bank grew its holdings in shares of Quaker Chemical by 5.1% during the second quarter. Amalgamated Bank now owns 1,810 shares of the specialty chemicals company’s stock worth $263,000 after buying an additional 88 shares in the last quarter. Finally, Advisor Group Inc. grew its holdings in shares of Quaker Chemical by 15.6% during the second quarter. Advisor Group Inc. now owns 954 shares of the specialty chemicals company’s stock worth $139,000 after buying an additional 129 shares in the last quarter. Institutional investors and hedge funds own 84.06% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: This piece of content was first published by Community Financial News and is the property of of Community Financial News. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this piece of content can be viewed at https://www.com-unik.info/2018/01/12/quaker-chemical-kwr-upgraded-by-zacks-investment-research-to-hold.html.
Quaker Chemical Company Profile
Quaker Chemical Corporation is a provider of process fluids, chemical specialties, and technical expertise to a range of industries, including steel, aluminum, mining, aerospace, tube and pipe, cans and others. The Company’s segments include North America, Europe, Middle East and Africa (EMEA), Asia/Pacific and South America.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Quaker Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quaker Chemical and related companies with MarketBeat.com's FREE daily email newsletter.